"Group Standard for Efficacy Evaluation of Probiotics in Obesity and Metabolic Syndrome" Officially Implemented — Bioyitech Leads the Future of Science-Based Precision Microecology

• Bioyitech deeply participates as a core drafting unit
• 9 proprietary Probiotic Strains (single and composite) included in the standard's appendix strain list
• Demonstrates the solid strength of "Precision Metabolic Health Microecology Solution Expert"

Recently, the group standard *"Efficacy Evaluation of Probiotics in Obesity and Metabolic Syndrome" (T/FDSA 0155—2026)* was officially implemented. Developed under the leadership of a national-level industry authority, this standard standardizes the efficacy validation, evaluation dimensions, and judgment criteria for related products. It establishes, for the first time in China, a foundational system for evaluating the metabolic health efficacy of probiotics, filling an industry gap and laying the cornerstone for the standardized and scientific development of this specialized field.

Nine Proprietary Probiotic Strains Included in the Standard’s Representative Strain List

In the representative strain list of the standard’s appendix, a total of nine proprietary probiotic strains from Bioyitech (seven single strains and two composite strains) have been included. These strains cover four core metabolic regulatory functions: blood glucose and insulin resistance regulation, blood lipid regulation, visceral fat reduction, and weight control. This fully demonstrates the company’s deep expertise and systematic innovation capability in the field of metabolic-regulating functional strains.

Clinically Evidenced Composite Strains: SugaRite™ and Purineed™ Lead the New Frontier of Metabolic Microecology

Beyond single strains, Bioyitech’s competitive edge lies in its composite strain products backed by clinical evidence. In Appendix B of the standard, two of Bioyitech’s core composite strain products — SugaRite™ (ZC-SUG II) and Purineed™ (ZC-URA II) — have been included, both supported by human clinical trial data as efficacy evidence. This carries significant weight within the entire standard appendix. 

Metabolic Health · Precision Microecology — Bioyitech’s Brand Differentiation Strategy

(I) Building Precision Metabolic Health Microecology Solutions Grounded in Scientific Evidence
Bioyitech provides partners with precision microecology solutions centered on metabolic pathway intervention, covering the entire lifecycle. The company focuses on the core metabolic health domains — blood glucose, weight, blood lipids, uric acid, and liver health — rooted in proprietary strain innovation and clinical-grade evidence. It offers a full-spectrum portfolio encompassing both live probiotics and postbiotics. Built upon the fundamental science of metabolic regulation, Bioyitech extends its solutions to adjacent areas such as bone health, skin health, and sports nutrition, while actively exploring related fields like emotional health and women’s health. Driven by verifiable and patentable microecology innovation, Bioyitech empowers partners worldwide.

(II) Evidence-Based Philosophy: Every Strain is Traceable and Verifiable

Bioyitech has always adhered to the evidence-based philosophy that "every strain is traceable and verifiable," building a systematic chain of evidence spanning in vitro screening, animal trials, and human clinical studies. Through its involvement in drafting this group standard, Bioyitech has infused its own evidence-based system and practical experience into the standard, driving the industry from "concept-driven marketing" toward "science-based evidence." The nine strains included in the standard’s appendix have all undergone rigorous scientific validation, with the two composite strains supported by human clinical trial data from tertiary hospitals — a testament to Bioyitech’s outstanding strength in the field of probiotic metabolic health.

From strain R&D to standard-setting, and from clinical evidence to industry empowerment, Bioyitech positions itself as the "Precision Metabolic Health Microecology Solution Expert." Focused on the development and industrial translation of proprietary patented strains, the company is committed to advancing China’s probiotic industry into a new era of high-quality development — grounded in science, led by standards, and driven by user value.